Focal Interest
Focal Interest

Reimbursement

  1. Rivaroxaban controversy linked to synthetic certainty
    Analysis of regulatory closure and synthetic certainization in rivaroxaban authorization, examining how institutional power consolidated therapeutic claims despite device defects.